 5. Clinically significant cardiovascular disease such as uncontrolled or symptomatic arrhythmias, congestive heart failure, or myocardial infarction within 6 months of Screening, or any Class 3 moderate or Class 4 severe cardiac disease as defined by the New York Heart Association Functional Classification. 